Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial). Local targets link to admitted publications; unresolved targets remain external evidence.
Current advancement in multidisciplinary treatment for resectable cstage II/III esophageal squamous cell carcinoma in Japan.
10.5761/atcs.ra.16-00111 · 2016 · External reference
Recent progress in multidisciplinary treatment for patients with esophageal cancer
10.1007/s00595-019-01878-7 · 2020 · External reference
A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).
10.1245/s10434-011-2049-9 · 2012 · External reference
A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study [ASCO Gastrointestinal Cancers Symposium Meeting Abstract].
10.1200/jco.2022.40.4_suppl.238 · 2022 · External reference
Survival benefit from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
10.1016/s1470-2045(07)70039-6 · 2007 · External reference
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
10.1016/s1470-2045(11)70142-5 · 2011 · External reference
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomized controlled trial.
10.1016/s1470-2045(15)00040-6 · 2015 · External reference
Pathological complete response in patients with esophageal cancer after the trimo-dality approach: the association with baseline variables and survival-the University of Texas MD Anderson Cancer Center experience
10.1002/cncr.30953 · 2017 · External reference
Adjuvant Nivolumab in resected esophageal or gastroesophageal junction cancer
10.1056/nejmoa2032125 · 2021 · External reference
Unresolved reference
2010 · External reference
Unresolved reference
External reference
Adjuvant chemotherapy for patients with pathologic node-positive esophageal cancer after induction chemotherapy is associated with improved survival
10.1016/j.jtcvs.2018.05.100 · 2018 · External reference
Adjuvant therapy for node-positive esophageal cancer after induction and surgery: a multisite study
10.1016/j.athoracsur.2019.04.099 · 2019 · External reference
